Effect of azithromycin on small bowel motility in patients with gastrointestinal dysmotility

Scandinavian Journal of Gastroenterology

Volumn 47, Issue 4, 2012, Pages 422-427

  Chini, Payam ^a   Toskes, Phillip P ^a   Waseem, Shamaila ^a   Hou, Wei ^a   McDonald, Renee ^a   Moshiree, Baharak ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

azithromycin; erythromycin; gastrointestinal dysmotility; small bowel dysmotility

Indexed keywords

AZITHROMYCIN; ERYTHROMYCIN; OCTREOTIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG HALF LIFE; FEMALE; GASTROINTESTINAL MOTILITY DISORDER; HUMAN; INTESTINAL DYSMOTILITY; INTESTINE CONTRACTION; INTESTINE MOTILITY; MALE; MANOMETRY; MIGRATING MOTOR COMPLEX; MIGRATING MYOELECTRIC COMPLEX; POSTPRANDIAL STATE; PRIORITY JOURNAL; STOMACH PARESIS;

ADULT; AGED; AZITHROMYCIN; ERYTHROMYCIN; FEMALE; GASTROINTESTINAL AGENTS; GASTROINTESTINAL MOTILITY; GASTROPARESIS; HUMANS; INTESTINE, SMALL; MALE; MANOMETRY; MIDDLE AGED; MYOELECTRIC COMPLEX, MIGRATING; OCTREOTIDE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84858645137     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2012.654402     Document Type: Article

References (25)

1. Hyett B, Martinez FJ, Gill BM, Mehra S, Lembo A, Kelly CP, et al. Delayed radionucleotide gastric emptying studies predict morbidity in diabetics with symptoms of gastroparesis. Gastroenterology 2009;137:445-52.
2. Jung HK, Choung RS, Locke GR, Schleck CD, Zinsmeister AR, Szarka LA, et al. The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996-2006. Gastroenterology 2009;136:1225-33.
3. Camilleri M, Malagelada JR. Abnormal intestinal motility in diabetics with the gastroparesis syndrome. Eur J Clin Invest 1984;14:420-7. (Pubitemid 15223753)
4. Bonapace ES, Maurer AH, Davidoff S, Krevsky B, Fisher RS, Parkman HP. Whole gut transit scintigraphy inthe clinical evaluation of patients with upper and lower gastrointestinal symptoms. Am J Gastroenterol 2000;95:2838-47.
5. Kuemmerle JF. Motility disorders of the small intestine: new insights into old problems. J Clin Gastroenterol 2000;31:276-81.
6. Haruma K, Wiste JA, Camilleri M. Effect of octreotide on gastrointestinal pressure profiles in health and in functional and organic gastrointestinal disorders. Gut 1994;35:1064-9. (Pubitemid 24244260)
7. Peeters TL, Janssens J, Vantrappen GR. Somatostatin and the interdigestive migrating motor complex in man. Regul Pept 1983;5:209-17. (Pubitemid 13132558)
8. Foxx-Orenstein A, Camilleri M, Stephens D, Burton D. Effect of a somatostatin analogue on gastric motor and sensory functions in healthy humans. Gut 2003;52:1555-61. (Pubitemid 37363437)
9. Otterson MF, Sarna SK. Gastrointestinal motor effects of erythromycin. Am J Physiol 1990;259:G355-63. (Pubitemid 20317843)
10. Tomomasa T, Karoumi T, Arai H, Wakabayashi K, Itoh Z. Erythromycin induces migrating motor complex in human gastrointestinal tract. Dig Dis Sci 1986;31:157-61. (Pubitemid 16167199)
11. Itoh Z, Nakaya M, Suzuki T, Arai H, Wakabayashi K. Erythromycin mimics exogenous motilin in gastrointestinal tract activity in the dog. Am J Physiol 1984;247:G688-G94.
12. Husebye E. The patterns of small bowel motility: physiology and implications in organic disease and functional disorders. Neurogastroenterol Motil 1999;11:141-61. (Pubitemid 29259606)
13. Ray WA, Murray KT, Meredith S, Narasimhulu SS, Hall K, Stein CM. Oral erythromycin and the risk of sudden death from cardiac issues. N Engl J Med 2004;351:1089-96.
14. Hopkins S. Clinical toleration and safety of azithromycin. Am J Med 1991;91:40S-5S.
15. Sifrim D, Matsuo H, Janssens J, Vantrappen G. Comparison of the effects of midecamycin acetate and azithromycin on gastrointestinal motility in man. Drugs Exp Clin Res 1994;20:121-6. (Pubitemid 24211103)
16. Sutera L, Dominguez LJ, Belvedere M, Putignano E, Vernuccio L, Ferlisi A, et al. Azithromycin in an older woman with diabetic gastroparesis. Am J Ther 2008;15:85-8. (Pubitemid 351161186)
17. Moshiree B, McDonald R, Hou W, Toskes PP. Comparison of the effect of azithromycin versus erythromycin on antro-duodenal pressure profiles of patients with chronic functional gastrointestinal pain and gastroparesis. Dig Dis Sci 2009;55:675-83.
18. Thumshirn M, Bruninga K, Camilleri M. Simplifying the evaluation of postprandial antral motor function in patients with suspected gastroparesis. Am J Gastroenterol 1997;92:1496-500. (Pubitemid 27412873)
19. Bortolotti M, Annese V, Coccia G. Twenty-four hour ambulatory antroduodenal manometry in normal subjects (cooperative study). Neurogastroenterol Motil 2000;12:231-8. (Pubitemid 30352704)
20. Parkman HP, Trate DM, Knight LC, Brown KL, Maurer AH, Fisher RS. Cholinergic effects on human gastric motility. Gut 1999;45:346-54. (Pubitemid 29400709)
21. Amsden GW. Erythromycin, clarithromycin, and azithromycin: are the differences real? Clin Ther 1996;18:56-72.
22. Desautels SG, Hutson WR, Christian PE, Moore JG, Datz FL. Gastric emptying response to variable oral erythromycin dosing in diabetic gastroparesis. Dig Dis Sci 1995;40:141-6.
23. Rubinstein E. Comparative safety of the different macrolides. Int J Antimicrob Agents 2001;18:S71-6. (Pubitemid 33713507)
24. Rapp RP. Pharmacokinetics and pharmacodynamics of intravenous and oral azithromycin: enhanced tissue activity and minimal drug interactions. Ann Pharmacother 1998;32:785-93. (Pubitemid 28341111)
25. Tougas G, Chen Y, Coates G, Paterson W, Dallaire C, Pare P, et al. Standardization of a simplified scintigraphic methodology for the assessment of gastric emptying in a multicenter setting. Am J Gastroenterol 2000;95:78-86. (Pubitemid 30041539)